Submit Deal

ALBUMEDIX

Summary

A science-driven, albumin focused biotechnology company

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 415 M

Avg. Deal Size£ 415 M

Market Context

Senior Management

Sort

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy